I. Kline

发表

Duration of drug levels in mice as indicated by residual antileukemic efficacy.

N. Mantel, A. Goldin, J. Venditti, 1968, Chemotherapia.

The effect of phenobarbital or 2-diethylaminoethyl-2,2-diphenylvalerate on the activation of cyclophosphamide in vivo.

J. Venditti, I. Kline, M. Gang, 1972, The Journal of pharmacology and experimental therapeutics.

Enhancement of the effectiveness of daunorubicin (NSC-82151) or adriamycin (NSC-123127) against early mouse L1210 leukemia with ICRF-159 (NSC-129943).

J. Venditti, I. Kline, M. Gang, 1975, Cancer chemotherapy reports.

Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2: Analysis of a Phase 1/2 Study

I. Kline, C. Dinardo, S. de Botton, 2018, JAMA oncology.

Enhanced response of leukemic (L1210) mice to combination chemotherapy with 5‐(3,3‐dimethyl‐1‐triazeno) imidazole‐4‐carboxamide (NSC‐45388) and 5‐fluorouracil (NSC‐19893)

A. Goldin, J. Venditti, I. Kline, 1971, Cancer.

Evaluation of antileukemic agents employing advanced leukemia L-1210 in mice. VI.

A. Goldin, J. Venditti, I. Kline, 1962, Cancer research.

Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea.

A. Goldin, J. Venditti, I. Kline, 1967, Cancer research.

Evaluation of antileukemic agents employing advanced leukemia L-1210 in mice. V.

A. Goldin, J. Venditti, I. Kline, 1964, Cancer research.

Damage induced in sarcoma 37 with chemical agents. VI. Biphenyl, fluorene, phenanthrene, and tropolone derivatives.

I. Kline, J. S. Kahler, J. Hartwell, 1953, Journal of the National Cancer Institute.

The freezing and preservation of animal tumors.

I. Kline, R. Trapani, 1964, Cryobiology.

Freezing and preservation of mouse tumor slices.

I. Kline, S. Schepartz, R. Trapani, 1962, Cancer chemotherapy reports.

Effect of frozen storage on the response to therapy of drug-resistant transplantable mouse tumors.

A. Goldin, J. Venditti, I. Kline, 1961, Cancer chemotherapy reports.

Preservation and characterization of cultured cells and animal tumors.

I. Kline, S. Schepartz, R. Acker, 1962, Cancer chemotherapy reports.

Sparing action of uridine on the activity of arabinosylcytosine with normal and leukemic mice.

I. Kline, G. Grindey, V. Waravdekar, 1968, Cancer research.

Chemotherapy of leukemia L1210 in mice with 1-beta-d-arabinofuranosylcytosine hydrochloride. I. Influence of treatment schedules.

A. Goldin, J. Venditti, I. Kline, 1966, Cancer research.

Influence of route of administration on antileukemic activity of cytosine arabinoside (NSC-63878) in advanced leukemia L1210 in mice.

A. Goldin, J. Venditti, I. Kline, 1968, Cancer chemotherapy reports.

Chemotherapy of leukemia L1210 in mice with 1-beta-D-arabinofuranosylcytosine hydrochloride. II. Effectiveness against intracerebrally and subcutaneously inoculated leukemic cells.

N. Mantel, A. Goldin, J. Venditti, 1966, Cancer research.

The influence of treatment schedule on the chemotheapy of advanced leukemia L1210 in mice.

A. Goldin, J. Venditti, I. Kline, 1960, Cancer chemotherapy reports.

Effect of combination treatment with 5-azacytidine and cytidine on the life-span and spleen and bone marrow cells of leukemic (L1210) and nonleukemic mice.

A. Goldin, I. Kline, V. Waravdekar, 1970, Cancer research.

Influence of the route of administration on the relative effectiveness of 3',5'-dichloroamethopterin and amethopterin against advanced leukemia (L1210) in mice.

A. Goldin, J. Venditti, I. Kline, 1960, Cancer research.

Comparison of 5-fluorouracil and ftorafur. I. Quantitative and qualitative differences in toxicity to mice.

A. Goldin, I. Kline, R. Johnson, 1976, Cancer treatment reports.

Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.

A. Goldin, J. Venditti, I. Kline, 1976, Cancer treatment reports.

Damage induced in sarcoma 37 with chemical agents. IV. Derivatives of colchicineamide.

I. Kline, M. V. Nadkarni, J. Hartwell, 1952, Journal of the National Cancer Institute.

Effectiveness of cytosine arabinoside therapy on leukemia (L-1210) of the central nervous system in mice arising during methotrexate treatment.

J. Venditti, I. Kline, M. Gang, 1968, Gan.

Studies of the L1210 antileukemic activity of O-2,2'-cyclocytidine, monoacetate (anhydro-ara-C; NSC-129220)--comparison with cytosine arabinoside (NSC-63878) with respect to treatment schedule dependency.

J. Venditti, I. Kline, M. Baratta, 1972, Cancer chemotherapy reports.

Eradication Of Leukaemic Cells (L1210) by Methotrexate and Methotrexate Plus Citrovorum Factor

N. Mantel, A. Goldin, J. Venditti, 1966, Nature.

Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. IV.

N. Mantel, A. Goldin, J. Venditti, 1961, Cancer research.

Studies on the effectiveness of 4',4"-di-2-imidazolin-2-ylterephthalanilides against mouse leukemia L1210 and resistant variants.

A. Goldin, J. Venditti, I. Kline, 1962, Cancer chemotherapy reports.

Therapeutic value of combination therapy with cytosine arabinoside (ara-c, nsc-63878) plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carb- oxamide (dic, nsc-45388) and enhancement of the combination with sequential methotrexate (mtx, nsc-740) in advanced murine leukemia l1210. Abstr.

J. Venditti, I. Kline, M. Gang, 1971 .

The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.

A. Goldin, J. Venditti, I. Kline, 1966, Cancer research.

1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and methotrexate (NSC-740) as combination therapy for advanced mouse leukemia L1210.

A. Goldin, J. Venditti, I. Kline, 1965, Cancer chemotherapy reports.

The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents.

J. Venditti, I. Kline, M. Gang, 1973, Chemotherapy.

Toxicity evaluation of doxorubicin entrapped in cardiolipin liposomes in mice. Abstr.

P. Schein, I. Kline, Aquilur Rahman, 1983 .

Adequacies and inadequacies in assessing murine toxicity data with antineoplastic agents.

H. H. Lloyd, J. Venditti, A. Guarino, 1979, Cancer research.

Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.

J. Venditti, I. Kline, M. Gang, 1973, Cancer chemotherapy reports.

Toxicity and antileukemic effectiveness of pyridine derivatives and 1,3,4-thiadiazole derivatives in mice. Relationship to nicotinamide antagonism.

N. Kaplan, A. Goldin, J. Venditti, 1962, Cancer research.

Evaluation of chemical agents against the plasma cell tumor LPC-1 in mice.

A. Goldin, J. Venditti, I. Kline, 1967, Biochemical pharmacology.

Evaluation of Combination Chemotherapy with Three Drugs 1

N. Mantel, A. Goldin, J. Venditti, 2006 .

Evaluation of combination chemotherapy with three drugs.

N Mantel, A Goldin, N. Mantel, 1968, Cancer research.

Potentially useful combinations of chemotherapy detected in mouse tumor systems.

I. Kline, 1974, Cancer chemotherapy reports. Part 2.

Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.

A. Goldin, J. Venditti, I. Kline, 1971, Cancer chemotherapy reports. Part 2.

Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.

A. Goldin, J. Venditti, I. Kline, 1972, Cancer chemotherapy reports. Part 2.

Effectiveness of cytosine arabinoside (ca) and other agents in the chemotherapy of early leukemia l1210 inoculated either intracerebrally (ic) or subcutaneously (sc). Abstr.

A. Goldin, J. Venditti, I. Kline, 1965 .

Sequential chemotherapy with cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in mice with advanced leukemia L1210.

N. Mantel, A. Goldin, J. Venditti, 1969, Cancer chemotherapy reports.

Differentiation syndrome associated with enasidenib, a selective inhibitor of mutant isocitrate dehydrogenase 2 (mIDH2).

I. Kline, C. Dinardo, A. Fathi, 2017 .